BIOLASE Common Stock Shares Outstanding vs Accounts Payable Analysis
BIOL Stock | USD 0.16 0.01 6.67% |
BIOLASE financial indicator trend analysis is way more than just evaluating BIOLASE prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BIOLASE is a good investment. Please check the relationship between BIOLASE Common Stock Shares Outstanding and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.
Common Stock Shares Outstanding vs Accounts Payable
Common Stock Shares Outstanding vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BIOLASE Common Stock Shares Outstanding account and Accounts Payable. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between BIOLASE's Common Stock Shares Outstanding and Accounts Payable is -0.08. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of BIOLASE, assuming nothing else is changed. The correlation between historical values of BIOLASE's Common Stock Shares Outstanding and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of BIOLASE are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Common Stock Shares Outstanding i.e., BIOLASE's Common Stock Shares Outstanding and Accounts Payable go up and down completely randomly.
Correlation Coefficient | -0.08 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Accounts Payable
An accounting item on the balance sheet that represents BIOLASE obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of BIOLASE are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from BIOLASE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BIOLASE current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.At this time, BIOLASE's Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 138.6 K this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.20.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 16.5M | 15.9M | 16.7M | 17.3M | Total Revenue | 39.2M | 48.5M | 49.2M | 38.5M |
BIOLASE fundamental ratios Correlations
Click cells to compare fundamentals
BIOLASE Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BIOLASE fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 31.8M | 41.0M | 55.3M | 38.2M | 35.1M | 31.3M | |
Short Long Term Debt Total | 13.5M | 18.0M | 15.1M | 15.1M | 17.9M | 18.8M | |
Other Current Liab | 4.7M | 6.4M | 7.9M | 9.2M | 8.0M | 8.4M | |
Total Current Liabilities | 25.8M | 11.2M | 13.8M | 17.8M | 19.7M | 14.3M | |
Total Stockholder Equity | 377K | 10.0M | 25.2M | 4.9M | (247K) | (234.7K) | |
Property Plant And Equipment Net | 1.5M | 2.8M | 2.8M | 6.0M | 7.0M | 7.4M | |
Net Debt | 7.7M | 396K | (14.9M) | 10.9M | 11.3M | 11.9M | |
Retained Earnings | (234.5M) | (251.4M) | (267.5M) | (296.2M) | (316.8M) | (301.0M) | |
Accounts Payable | 5.3M | 2.7M | 3.3M | 5.8M | 6.1M | 4.9M | |
Cash | 5.8M | 17.6M | 30.0M | 4.2M | 6.6M | 7.9M | |
Non Current Assets Total | 4.8M | 5.9M | 5.9M | 9.2M | 10.2M | 5.7M | |
Non Currrent Assets Other | 433K | 231K | 220K | 255K | 268K | 277.2K | |
Cash And Short Term Investments | 5.8M | 17.6M | 30.0M | 4.2M | 6.6M | 9.6M | |
Net Receivables | 8.8M | 3.1M | 4.2M | 5.8M | 5.5M | 6.3M | |
Common Stock Shares Outstanding | 9.3K | 24.5K | 59.1K | 69.3K | 1.3M | 1.3M | |
Liabilities And Stockholders Equity | 31.8M | 41.0M | 55.3M | 38.2M | 35.1M | 31.3M | |
Non Current Liabilities Total | 5.7M | 19.8M | 16.2M | 15.5M | 15.7M | 16.5M | |
Inventory | 11.0M | 11.2M | 12.9M | 15.9M | 11.4M | 8.1M | |
Other Current Assets | 1.2M | 3.0M | 2.0M | 3.1M | 1.4M | 1.5M | |
Other Stockholder Equity | 231.6M | 261.6M | 293.2M | 301.8M | 314.9M | 330.6M | |
Total Liab | 31.5M | 31.0M | 30.1M | 33.3M | 35.3M | 18.3M | |
Property Plant And Equipment Gross | 1.5M | 2.8M | 2.8M | 6.0M | 18.4M | 19.3M | |
Total Current Assets | 27.0M | 35.1M | 49.4M | 29.0M | 24.9M | 25.5M | |
Accumulated Other Comprehensive Income | (701K) | (385K) | (623K) | (733K) | (553K) | (580.7K) | |
Short Term Debt | 13.5M | 305K | 405K | 700K | 3.2M | 2.9M | |
Common Stock Total Equity | 102K | 21K | 31K | 98K | 112.7K | 118.3K | |
Common Stock | 31K | 98K | 154K | 8K | 3K | 2.9K | |
Other Assets | 433K | 2.2M | 220K | 255K | 229.5K | 218.0K | |
Property Plant Equipment | 1.2M | 2.8M | 2.8M | 6.0M | 7.0M | 7.3M | |
Other Liab | 1.7M | 1.8M | 1.2M | 1.1M | 1.0M | 1.1M | |
Current Deferred Revenue | 2.2M | 1.9M | 2.3M | 2.1M | 2.5M | 2.3M | |
Net Tangible Assets | 8.2M | 1.4M | 7.0M | 22.2M | 20.0M | 12.3M | |
Retained Earnings Total Equity | (195.2M) | (216.7M) | (234.5M) | (251.4M) | (226.2M) | (237.6M) | |
Capital Surpluse | 224.9M | 228.4M | 235.6M | 261.6M | 300.8M | 214.9M | |
Deferred Long Term Liab | 115K | 77K | 436K | 374K | 336.6K | 368.5K | |
Non Current Liabilities Other | 1.3M | 1.1M | 330K | 362K | 79K | 75.1K |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as BIOLASE using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for BIOLASE Stock analysis
When running BIOLASE's price analysis, check to measure BIOLASE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOLASE is operating at the current time. Most of BIOLASE's value examination focuses on studying past and present price action to predict the probability of BIOLASE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIOLASE's price. Additionally, you may evaluate how the addition of BIOLASE to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is BIOLASE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIOLASE. If investors know BIOLASE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIOLASE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.97) | Revenue Per Share 8.632 | Quarterly Revenue Growth (0.03) | Return On Assets (0.26) | Return On Equity (5.05) |
The market value of BIOLASE is measured differently than its book value, which is the value of BIOLASE that is recorded on the company's balance sheet. Investors also form their own opinion of BIOLASE's value that differs from its market value or its book value, called intrinsic value, which is BIOLASE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIOLASE's market value can be influenced by many factors that don't directly affect BIOLASE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIOLASE's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIOLASE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIOLASE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.